Eli Samaha, 10% Owner at Theravance Biopharma, Inc. (TBPH), bought 999,800 shares at $7.80 ($7.8M) on 2024-08-07, disclosed to the SEC on 2024-08-09.
Open-market purchase of $7.8M TBPH by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| STGW | BUY | 2025-05-13 | $1.9M | — | Filing → |
| TBPH | BUY | 2024-05-03 | $13.1M | — | Filing → |
| STGW | BUY | 2023-03-14 | $5.1M | — | Filing → |